Cargando…

Case report: follow-up of long term prophylaxis of hereditary angioedema with an alternative attenuated androgenic drug

Detalles Bibliográficos
Autor principal:	Tebyrica, João
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407073/ http://dx.doi.org/10.1186/1939-4551-8-S1-A274

Ejemplares similares

Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
por: Guo, Yinshi, et al.
Publicado: (2022)

Long-term prophylaxis of hereditary angioedema with danazol
por: Xu, Yingyang, et al.
Publicado: (2022)

Type-III hereditary angioedema resolved by surgery
por: Fu, Lisa W, et al.
Publicado: (2014)

Therapeutic trial in hereditary angioedema type III: Icatibant
por: Garro, Laila Sabino, et al.
Publicado: (2015)

Early presentation of clinical hereditary angioedema symptoms in an infant
por: Pham, Hoang, et al.
Publicado: (2014)

Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab
por: Wong, Jane C.Y., et al.
Publicado: (2023)

A new mutation in the SERPING1 gene in a Brazilian family with hereditary angioedema
por: Da Silva, Jane, et al.
Publicado: (2015)

Hereditary angioedema without deficiency of C1 inhibitor: response to therapy
por: Pimenta, Fabiane Milena Castro Araújo, et al.
Publicado: (2015)

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
por: Yang, William, et al.
Publicado: (2014)

Short-term prophylaxis (STP) with plasma derived human C1 inhibitor concentrate (pdhC1-INH) in two pregnant women with hereditary angioedema (HAE): an experience in Rio de Janeiro – Brazil
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Hereditary angioedema with C1 inhibitor deficiency: experience of a new reference center
por: Palma, Sandra Mitie Ueda, et al.
Publicado: (2015)

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)

Informed decision‐making in hereditary angioedema prophylaxis
por: Burnette, Autumn Ford
Publicado: (2021)

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema
por: Craig, Timothy, et al.
Publicado: (2017)

Clinical and epidemiological profile of patients with hereditary angioedema treated in a referral outpatient clinic in Vitória, Espírito Santo - Brazil
por: Arantes, Rafael Cicconi, et al.
Publicado: (2015)

Short-term Prophylaxis for Delivery in Pregnant Women with Hereditary Angioedema with Normal C1-Inhibitor
por: Moraes, Caroline Guth de Freitas Batista de, et al.
Publicado: (2020)

Treatment of hereditary angioedema with recombinant human C1 Inhibitor in a real-life setting: the experience of the HAE Centre in Milan
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Self-administration of intravenous C1 esterase inhibitor (Berinertâ) in patients with Hereditary Angioedema decreases number of days spent in an emergency room
por: Rizk, Caroline, et al.
Publicado: (2011)

Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
por: Santucci, Stephanie, et al.
Publicado: (2014)

Hereditary Angioedema with Normal C1 Esterase Inhibitor Refractory to Long-Term Prophylaxis: A Case Report
por: Cobb, Gavin, et al.
Publicado: (2023)

Evaluation of patients with angioedema in accompaniment in the allergy and immunology HSPE / SP
por: Marculino, Marilise, et al.
Publicado: (2015)

Hereditary angioedema
por: Lesser, Helen, et al.
Publicado: (2021)

Hereditary Angioedema
por: Banerjee, Anjali, et al.
Publicado: (2023)

Hereditary angioedema patients would prefer newer-generation oral prophylaxis
por: Geba, Daniela, et al.
Publicado: (2021)

Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema
por: Gower, Richard G., et al.
Publicado: (2021)

Long-term follow up of traumatic multiple rib fractures
por: Kawamae, K, et al.
Publicado: (2001)

Angioedema in the emergency department: clinical presentation and outcomes
por: Felder, Sarah L, et al.
Publicado: (2014)

Melkersson-rosenthal syndrome associated with 21 trisomy as a differential diagnosis of angioedema
por: Monteiro, Mariana, et al.
Publicado: (2015)

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
por: Aberer, Werner, et al.
Publicado: (2017)

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
por: Kőhalmi, Kinga Viktória, et al.
Publicado: (2016)

A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis
por: Mendivil, Joan, et al.
Publicado: (2023)

Treatment of angiotensin-converting enzyme inhibitor related angioedema with icatibant
por: Ho, Peter, et al.
Publicado: (2014)

Hereditary angioedema in women
por: Bouillet, Laurence
Publicado: (2010)

Hereditary Angioedema: Not An Allergy
por: Bhivgade, Sanjay, et al.
Publicado: (2012)

The Pathophysiology of Hereditary Angioedema
por: Zuraw, Bruce L
Publicado: (2010)

Pediatric hereditary angioedema
por: MacGinnitie, Andrew J
Publicado: (2014)

Hereditary angioedema in childhood
por: Ahn, Young Min
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ckpsdvvg37nnvo26hvbe6bs8tc